Department of Maternal and Pediatric Sciences, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Hum Vaccin Immunother. 2012 Jan;8(1):102-6. doi: 10.4161/hv.8.1.17957. Epub 2012 Jan 1.
Every year for the last few decades, the health authorities of most countries throughout the world have issued specific recommendations for the prevention and treatment of pediatric influenza, including recommendations concerning the use of vaccines. However, different evaluations of the importance of the disease and the efficacy of influenza vaccination frequently lead to conflicting recommendations. This is clearly demonstrated not only by the differences in the subjects for whom the vaccine is recommended, but also by the inaccurate manner in which subjects at risk of influenza-related complications are defined. Only further studies that consider the burden of the disease and vaccine efficacy in adequate numbers of healthy children and high-risk children with different chronic underlying diseases can overcome all of the current limitations and significantly improve vaccination coverage in both categories.
在过去几十年中,世界上大多数国家的卫生当局每年都会针对儿科流感的预防和治疗发布具体建议,包括有关疫苗使用的建议。然而,对疾病重要性和流感疫苗接种效果的不同评估常常导致相互矛盾的建议。这不仅表现在推荐疫苗的人群不同,还表现在对流感相关并发症高危人群的定义不准确。只有进一步的研究,在足够数量的健康儿童和患有不同慢性基础疾病的高危儿童中考虑疾病负担和疫苗效果,才能克服目前所有的局限性,并显著提高这两类人群的疫苗接种率。